Bladder Cancer

Bladder Cancer
2021-06-09T00:00:00.000+01:00
Ongoing

KEYNOTE-992

KEYNOTE-992
Bladder cancer

A Phase 3, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Chemoradiotherapy (CRT) Versus CRT Alone in Participants with Muscle-invasive Bladder Cancer (MIBC)

A Phase 3, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Chemoradiotherapy (CRT) Versus CRT Alone in Participants with Muscle-invasive Bladder Cancer (MIBC)

Trial overview

Clinical Area

Medical Oncology

Disease / Condition

Bladder

Study Phase

III

Trial Identifiers

Registration number: NCT04241185

https://www.clinicaltrials.gov/study/NCT04241185

GenesisCare Location(s)
North Shore
location pin icon

North Shore Health Hub, Tower A, Level 1, 7 Westbourne St, St Leonards, NSW, 2065, Australia

phone icon (02) 8037 4100 email icon admin.northshore@genesiscare.com
NSW
North Shore
Principal Investigator(s)
Medical Oncologist

Dr Laurence Krieger

MBChB (Hons) FRACP

Dr Laurence Krieger
location pin icon

North Shore

View Profile
Profile Image - Dr Laurence Krieger

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.